These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38888389)

  • 21. Impact of European Union label changes to avoid inadvertent use of medicinal products containing methotrexate for once-weekly administration: A survey amongst prescribers, pharmacists and patients on awareness, knowledge, and behaviour.
    Lysen T; Karimi L; Wang M; Singh S; Toussi M
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5692. PubMed ID: 37661305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The implementation of risk minimization measures to prevent teratogenic pregnancy outcomes related to oral retinoid and valproate use in Belgium.
    Bertels X; Mehuys E; Boussery K; Lahousse L
    Acta Clin Belg; 2022 Oct; 77(5):815-822. PubMed ID: 34569444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review of Workplace Risk Management Measures for Nanomaterials to Mitigate Inhalation and Dermal Exposure.
    Goede H; Christopher-de Vries Y; Kuijpers E; Fransman W
    Ann Work Expo Health; 2018 Oct; 62(8):907-922. PubMed ID: 30084914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries.
    von Bredow D; Toussi M; Samad A; Kaplan S; Domahidy M; de Voogd H; Böhmert S; Ramos RS; Arora D
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1385-1392. PubMed ID: 30379361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Not every delirium protocol in Dutch hospitals is up-to-date: evaluation of the implementation of the new delirium guideline].
    Kentin ZH; Dautzenberg PL; Boelens HM; de Rooij SE; van Munster BC
    Ned Tijdschr Geneeskd; 2016; 160():D151. PubMed ID: 27438389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic approach to implementing and evaluating clinical guidelines: The results of fifteen years of Preventive Child Health Care guidelines in the Netherlands.
    Fleuren MA; van Dommelen P; Dunnink T
    Soc Sci Med; 2015 Jul; 136-137():35-43. PubMed ID: 25982867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women.
    Langner JL; Chiang KF; Stafford RS
    Am J Obstet Gynecol; 2021 Sep; 225(3):272.e1-272.e11. PubMed ID: 33848538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.
    Abtahi S; Pajouheshnia R; Durán CE; Riera-Arnau J; Gamba M; Alsina E; Hoxhaj V; Andersen M; Bartolini C; Kristiansen SB; Brown J; Hallgreen CE; Garcia-Poza P; Gardarsdottir H; Gini R; Girardi A; Holthuis E; Huerta C; Ibánez L; Limoncella G; Martín-Pérez M; Paoletti O; Roberto G; Souverein P; Swart KMA; Wing K; Sturkenboom M; Klungel O
    Drug Saf; 2023 Jul; 46(7):689-702. PubMed ID: 37294532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The health and budget impact of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in The Netherlands.
    van Schoonhoven AV; Schöttler MH; Serné EH; Schrömbges PPG; Postma MJ; Boersma C
    J Med Econ; 2023; 26(1):547-553. PubMed ID: 36987694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electroconvulsive therapy in the Netherlands: the practice in 2015 compared to that in 2008].
    Verwey B; Tuerlings JHAM; van Waarde JA
    Tijdschr Psychiatr; 2017; 59(12):775-779. PubMed ID: 29251750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Manoguerra AS; Erdman AR; Woolf AD; Chyka PA; Caravati EM; Scharman EJ; Booze LL; Christianson G; Nelson LS; Cobaugh DJ; Troutman WG;
    Clin Toxicol (Phila); 2008 Aug; 46(7):661-76. PubMed ID: 18608263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force.
    Warlé-van Herwaarden MF; Kramers C; Sturkenboom MC; van den Bemt PM; De Smet PA;
    Drug Saf; 2012 Mar; 35(3):245-59. PubMed ID: 22339574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of international guideline programs to evaluate and update the Dutch program for clinical guideline development in physical therapy.
    Van der Wees PJ; Hendriks EJ; Custers JW; Burgers JS; Dekker J; de Bie RA
    BMC Health Serv Res; 2007 Nov; 7():191. PubMed ID: 18036215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.
    Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
    Osteoarthritis Cartilage; 2007 Sep; 15(9):981-1000. PubMed ID: 17719803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective multicenter evaluation of adherence to the Dutch guideline for children aged 0-16 years with fever without a source-febrile illness in children (FINCH) study.
    Keuning MW; Klarenbeek NN; Bout HJ; Broer A; Draaijer M; Hol J; Hollander N; Merelle M; Nassar-Sheikh Rashid A; Nusman C; Oostenbroek E; Ridderikhof ML; Roelofs M; van Rossem E; van der Schoor SRD; Schouten SM; Taselaar P; Vasse K; van Wermeskerken AM; van der Zande JMJ; Zuurbier R; Bijlsma MW; Pajkrt D; Plötz FB
    Eur J Pediatr; 2024 Jul; 183(7):2921-2933. PubMed ID: 38619569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in safety monitoring of biologic response modifiers after the implementation of clinical care guidelines by a specialty.
    Hanson RL; Gannon MJ; Khamo N; Sodhi M; Orr AM; Stubbings J
    J Manag Care Pharm; 2013; 19(1):49-67. PubMed ID: 23383700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers encountered during the implementation of a policy guideline on the vaccination of health care workers during the 2013-2014 measles outbreak in the Netherlands: a qualitative study.
    Borggreve SJ; Timen A
    BMC Res Notes; 2015 Dec; 8():780. PubMed ID: 26667824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.